Prevalence of SARS-CoV-2 RNA and antibody-detection, and vaccination status in patients with ocular vascular occlusion.
Adrianna U DeraTobias BrockmannWladislaw RuschAda L WeilandEmil C ReisingerThomas A FuchslugerClaudia BrockmannPublished in: Retina (Philadelphia, Pa.) (2023)
Our study did not reveal an increased annual prevalence of ocular vascular occlusions during COVID-19 pandemic years 2020 and 2021. Patients with previous COVID vaccination did not present differences regarding the risk profile nor symptoms, compared to unvaccinated individuals.